Found: 27
Select item for more details and to access through your institution.
RESPONSE TO LISTENING TO MIFEPRISTONE.
- Published in:
- New York University Annual Survey of American Law, 2023, v. 80, n. 1, p. 63
- By:
- Publication type:
- Article
CLOSING THE REGULATORY GAP FOR SYNTHETIC NICOTINE PRODUCTS.
- Published in:
- Boston College Law Review, 2018, v. 59, n. 6, p. 1932
- By:
- Publication type:
- Article
The Strange Allure of State "Right-to-Try" Laws.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 12, p. 1885, doi. 10.1001/jamainternmed.2014.5767
- By:
- Publication type:
- Article
23andMe, the Food and Drug Administration, and the Future of Genetic Testing.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 4, p. 493, doi. 10.1001/jamainternmed.2013.14706
- By:
- Publication type:
- Article
Promoting Patient Interests in Implementing the Federal Right to Try Act.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anticipating Industry Arguments: The US Food and Drug Administration's Authority to Reduce Nicotine Levels in Cigarettes.
- Published in:
- Public Health Reports, 2018, v. 133, n. 4, p. 502, doi. 10.1177/0033354918776935
- By:
- Publication type:
- Article
State Regulation of Biomedical Citizen Science.
- Published in:
- Citizen Science: Theory & Practice, 2022, v. 7, n. 1, p. 1, doi. 10.5334/cstp.526
- By:
- Publication type:
- Article
Pharmaceutical Federalism.
- Published in:
- Indiana Law Journal, 2017, v. 92, n. 3, p. 845
- By:
- Publication type:
- Article
Compassionate use of experimental therapies: who should decide?
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 10, p. 1248, doi. 10.15252/emmm.201505262
- By:
- Publication type:
- Article
Broader Implications of Eliminating FDA Jurisdiction Over Execution Drugs.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
RETHINKING INNOVATION AT FDA.
- Published in:
- Boston University Law Review, 2024, v. 104, n. 2, p. 513
- By:
- Publication type:
- Article
The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1666, doi. 10.7326/M23-2431
- By:
- Publication type:
- Article
Mifepristone, preemption, and public health federalism.
- Published in:
- Journal of Law & the Biosciences, 2022, v. 9, n. 2, p. 1, doi. 10.1093/jlb/lsac037
- By:
- Publication type:
- Article
The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues.
- Published in:
- Journal of Law & the Biosciences, 2020, v. 7, n. 1, p. 1, doi. 10.1093/jlb/lsaa069
- By:
- Publication type:
- Article
Regulatory flexibility for COVID-19 research.
- Published in:
- Journal of Law & the Biosciences, 2020, v. 7, n. 1, p. 1, doi. 10.1093/jlb/lsaa057
- By:
- Publication type:
- Article
The stem cell market and policy options: a call for clarity.
- Published in:
- Journal of Law & the Biosciences, 2018, v. 5, n. 3, p. 743, doi. 10.1093/jlb/lsy025
- By:
- Publication type:
- Article
Is it 'gene therapy'?
- Published in:
- Journal of Law & the Biosciences, 2018, v. 5, n. 3, p. 786, doi. 10.1093/jlb/lsy020
- By:
- Publication type:
- Article
What lies ahead for FDA regulation of tDCS products?
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Regulating drug promotion to promote the public health: a response to Bennett et al.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
3. Synthetic nicotine: science, global legal landscape and regulatory considerations.
- Published in:
- WHO Technical Report Series, 2023, n. 1047, p. 35
- By:
- Publication type:
- Article
DIY CRISPR.
- Published in:
- North Carolina Law Review, 2019, v. 97, n. 5, p. 1399
- By:
- Publication type:
- Article
The Indirect Consequences of Expanded Off-Label Promotion.
- Published in:
- Ohio State Law Journal, 2017, v. 78, n. 4, p. 1053
- By:
- Publication type:
- Article
The FDA's Power Over Non-Therapeutic Uses of Drugs and Devices.
- Published in:
- Washington & Lee Law Review, 2021, v. 78, n. 1, p. 379
- By:
- Publication type:
- Article
Realizing Present and Future Promise of DIY Biology and Medicine through a Trust Architecture.
- Published in:
- Hastings Center Report, 2020, v. 50, n. 6, p. 10, doi. 10.1002/hast.1194
- By:
- Publication type:
- Article
Prevalence of Publicly Available Expanded Access Policies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 1016, doi. 10.1002/cpt.996
- By:
- Publication type:
- Article
Toward Coherent Federal Oversight of Medicine.
- Published in:
- San Diego Law Review, 2015, v. 52, n. 2, p. 427
- By:
- Publication type:
- Article